40 results on '"Pugliese, Steven"'
Search Results
2. Abstract 16338: Outcomes in Patients With High-Risk Pulmonary Embolism Undergoing Extracorporeal Membrane Oxygenation and Adjunctive Treatment Strategy, Including Percutaneous and Surgical Management- A Retrospective Study at a Tertiary Care Center
3. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension
4. BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis
5. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension
6. Bleeding risk by intensity of anticoagulation in critically ill patients with COVID‐19: A retrospective cohort study
7. A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension
8. Interventional Therapies in Acute Pulmonary Embolism
9. Adventitial Fibroblasts Induce a Distinct Proinflammatory/Profibrotic Macrophage Phenotype in Pulmonary Hypertension
10. Unexplained Dyspnea: Hepatopulmonary Syndrome without Cirrhosis?
11. Management of Acute Pulmonary Embolism
12. The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function
13. Hypoxic Pulmonary Hypertension
14. Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States
15. Pulmonary artery compliance in different forms of pulmonary hypertension.
16. Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants
17. Current interventional therapies in acute pulmonary embolism
18. EXPRESS: Systemic Arterial Properties in Pulmonary Hypertension
19. Health Related Quality of Life and Hospitalizations In Chronic Thromboembolic Pulmonary Hypertension Versus Idiopathic Pulmonary Arterial Hypertension: An Analysis from the Pulmonary Hypertension Association (PHAR)
20. Anticoagulation in Pulmonary Arterial Hypertension
21. Hypoxic Pulmonary Hypertension
22. Characteristics, Outcomes, and Trends of Patients With COVID-19–Related Critical Illness at a Learning Health System in the United States
23. Mid-term outcomes with the use of extracorporeal membrane oxygenation for cardiopulmonary failure secondary to massive pulmonary embolism
24. Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims
25. Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension?
26. The Post–Pulmonary Embolism Syndrome: Real or Ruse?
27. Abstract 4: Disparities in the Use of Direct Oral Anticoagulant Treatment of Venous Thromboembolism in the United States, 2010-2016
28. Interventional Therapies in Acute Pulmonary Embolism
29. Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension
30. The R213G Polymorphism in SOD3 Protects Early Bleomycin-Induced Pulmonary Inflammation and Attenuates Induction of Genes Involved in Agranulocyte/granulocyte Adhesion and Diapedesis
31. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes
32. 118 - The R213G Polymorphism in SOD3 Protects Early Bleomycin-Induced Pulmonary Inflammation and Attenuates Induction of Genes Involved in Agranulocyte/granulocyte Adhesion and Diapedesis
33. Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension.
34. Adventitial Fibroblasts Induce a Distinct Proinflammatory/ Profibrotic Macrophage Phenotype in Pulmonary Hypertension.
35. Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)
36. Systemic arterial properties in pulmonary hypertension
37. Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
38. Novel Liver Injury Phenotypes and Outcomes in Pulmonary Arterial Hypertension.
39. Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and Mitochondrial Respiration.
40. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.